Wainwright reiterates Buy on Connect Biopharma; $7 target
HC Wainwright & Co. reiterated a Buy rating on Connect Biopharma Holdings and set a $7.00 price target.
Story updates
11:06:29 AM UTC
SquawkNews
Connect Biopharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.